CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
200 hedge funds and large institutions have $2.73B invested in Cymabay Therapeutics in 2023 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding
Funds holding: 189 → 200 (+11)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Holders
200
Holding in Top 10
10
Calls
$84.7M
Puts
$20.6M
Top Buyers
| 1 | +$60.5M | |
| 2 | +$42.9M | |
| 3 | +$35.3M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$33.3M |
| 5 |
Morgan Stanley
New York
|
+$33.2M |
Top Sellers
| 1 | -$48.4M | |
| 2 | -$35.4M | |
| 3 | -$33.2M | |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$26.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$16.5M |